Novel scoring tool of hypoxemic respiratory failure and pulmonary hypertension for defining severity of persistent pulmonary hypertension of newborn.


Journal

Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884

Informations de publication

Date de publication:
10 2023
Historique:
received: 22 05 2023
accepted: 21 08 2023
revised: 02 08 2023
medline: 5 10 2023
pubmed: 26 8 2023
entrez: 25 8 2023
Statut: ppublish

Résumé

To obtain preliminary validity data for a hypoxemic respiratory failure/pulmonary hypertension (HRF/PH) score for classifying persistent pulmonary hypertension of the newborn (PPHN). Retrospective chart review of 100 consecutive neonates admitted to a Children's hospital from 2016-2021 with PPHN, gestational age ≥34 weeks, and echocardiograms in the first week. We assessed the correlation between HRF/PH score and short-term outcomes using linear and logistic regressions. HRF/PH scores ranged 2-12 (mean 8.5), and were classified mild (0-5), moderate (6-10), and severe (11-15), with 6%, 77% and 17% infants in respective categories. HRF/PH score category correlated with invasive ventilation, nitric oxide, high frequency ventilation, vasoactive infusions, extracorporeal life support and death. HRF/PH score category did not correlate with duration of support or length of stay. The HRF/PH score offers a promising representation of disease severity for PPHN. The tool requires further validation in prospective studies and evaluation for long-term outcomes.

Identifiants

pubmed: 37626160
doi: 10.1038/s41372-023-01762-w
pii: 10.1038/s41372-023-01762-w
pmc: PMC10541330
doi:

Substances chimiques

Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1281-1287

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001859
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD072929
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001860
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

J Perinatol. 2021 Jan;41(1):32-38
pubmed: 32792635
Eur Heart J. 1986 Aug;7(8):704-10
pubmed: 2945720
N Engl J Med. 1997 Feb 27;336(9):605-10
pubmed: 9032045
J Pediatr. 2009 Mar;154(3):379-84, 384.e1-2
pubmed: 18950791
Semin Perinatol. 1997 Oct;21(5):418-25
pubmed: 9352614
Pediatr Cardiol. 2015 Jan;36(1):233-9
pubmed: 25107548
Cardiol Young. 2004 Jun;14(3):277-83
pubmed: 15680021
Circulation. 1983 Jul;68(1):68-75
pubmed: 6851056
Eur Heart J Cardiovasc Imaging. 2015 Nov;16(11):1224-31
pubmed: 25851325
Matern Health Neonatol Perinatol. 2017 Nov 27;3:27
pubmed: 29209510
J Perinatol. 2010 Jun;30(6):420-4
pubmed: 19890345
Pak J Med Sci. 2021 Sep-Oct;37(5):1387-1391
pubmed: 34475917
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Pediatrics. 1997 Jun;99(6):838-45
pubmed: 9190553
Semin Fetal Neonatal Med. 2022 Aug;27(4):101381
pubmed: 35963740
Pediatr Cardiol. 2021 Dec;42(8):1848-1853
pubmed: 34331558
Semin Perinatol. 2014 Mar;38(2):78-91
pubmed: 24580763
Clin Perinatol. 1999 Sep;26(3):601-19
pubmed: 10494467
J Pediatr. 2016 Oct;177:90-96.e3
pubmed: 27502103
Trials. 2014 Dec 12;15:486
pubmed: 25496504
Clin Ther. 2010 May;32(5):939-48
pubmed: 20685502
Neonatology. 2011;100(1):85-92
pubmed: 21273793
J Am Coll Cardiol. 1985 Aug;6(2):359-65
pubmed: 4019921
Clin Perinatol. 2021 Aug;48(3):595-618
pubmed: 34353582
Pediatr Cardiol. 1997 Jul-Aug;18(4):270-5
pubmed: 9175523
Children (Basel). 2022 Mar 11;9(3):
pubmed: 35327768
Pediatrics. 2004 Mar;113(3 Pt 1):559-64
pubmed: 14993550
J Am Coll Cardiol. 1985 Oct;6(4):750-6
pubmed: 4031289
Matern Health Neonatol Perinatol. 2018 Dec 3;4:24
pubmed: 30524749
Circulation. 1984 Oct;70(4):657-62
pubmed: 6478568
Pediatrics. 2017 Jan;139(1):
pubmed: 27940508
J Paediatr Child Health. 2019 Jul;55(7):753-761
pubmed: 30537276
Pediatr Cardiol. 2009 Feb;30(2):160-5
pubmed: 18779989
Lancet. 1992 Oct 3;340(8823):819-20
pubmed: 1357246

Auteurs

Sage Timberline (S)

Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.

Avni Bhatt (A)

School of Medicine, University of California, Davis, Sacramento, CA, USA.

Sherzana Sunderji (S)

Department of Pediatrics, University of California, Davis, Sacramento, CA, USA.

Daniel J Tancredi (DJ)

Department of Pediatrics, University of California, Davis, Sacramento, CA, USA.

Satyan Lakshminrusimha (S)

Department of Pediatrics, University of California, Davis, Sacramento, CA, USA.

Heather Siefkes (H)

Department of Pediatrics, University of California, Davis, Sacramento, CA, USA. hsiefkes@ucdavis.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH